Cadila Aims to take 30 Percent share of Oncology drugs
Cadila will supply the oncology drug to joint venture partner Hospira.
Upcoming Events
Cadila will supply the oncology drug to joint venture partner Hospira.
Enter your email to receive a weekly round-up of our best posts.